Unlock instant, AI-driven research and patent intelligence for your innovation.

Ssm6a recombinant expression and purification method and used fusion protein

A fusion protein and purification tag technology, applied in the field of large-scale recombinant expression and purification of polypeptides, to achieve the effect of expanding production scale and saving production costs

Inactive Publication Date: 2018-06-05
南通迈克爱伦医药有限公司
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although thioredoxin and enterokinase are used in the prokaryotic recombinant expression and purification method disclosed therein, the direct and correct expression of the product still cannot be achieved, and an additional in vitro renaturation step is required to obtain the active conotoxin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ssm6a recombinant expression and purification method and used fusion protein
  • Ssm6a recombinant expression and purification method and used fusion protein
  • Ssm6a recombinant expression and purification method and used fusion protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0125] Embodiment 1 genetic recombination engineering bacteria construction

[0126] Design the fusion expression sequence (SEQID NO:1) including thioredoxin-6×His-tag-enterokinase cleavage site-Ssm6a, and then optimize its coding gene sequence according to the codon preference of Escherichia coli to obtain the final optimization The final coding nucleotide sequence, SEQ ID NO: 2, was commissioned to be synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd. (synthesis order number: 80-28327346).

[0127] The synthesized gene fragment was digested with Nde I and Xho I (Fermentas Company), and connected to the pET28a plasmid (product of Novagen Company, operated according to the manufacturer's suggestion) after double digestion with the same enzymes. The ligated recombinant pET28a plasmid was sent to Sangon Bioengineering (Shanghai) Co., Ltd. for sequencing verification (sequence number: CX170710388-S), and the sequence was confirmed to be correct.

[0128] CaCl 2 Prepare Esc...

Embodiment 2

[0129] Embodiment 2 Recombinant Engineering Bacteria Shake Flask Fermentation

[0130] The strains finally obtained in Example 1 were inoculated into 100 ml LB medium (containing 50 μg / ml kanamycin) at 220 rpm (revolutions per minute), and cultivated overnight at 37° C. as seeds. Inoculate 10L of LB medium (containing kanamycin 50μg / ml) according to the volume ratio of 1% for fermentation (2L shake flask, liquid volume 1L, 10 bottles in total): first, 220rpm, 37°C to OD 600 After reaching 0.8, adjust the temperature to 30°C, add IPTG (final concentration 0.2mM) to induce protein expression for 8h (hours), and centrifuge at 8000rpm for 5min (minutes) to harvest the cells.

Embodiment 3

[0131] Embodiment 3 Recombinant Engineering Bacteria 15L Tank Fermentation

[0132] The strains finally obtained in Example 1 were inoculated into 320 ml LB medium (containing 50 μg / ml kanamycin), 220 rpm, and cultured overnight at 37° C. as seeds. The overnight seeds were inoculated in 8 L of LB medium (containing 50 μg / ml kanamycin) at a volume ratio of 4%. The initial temperature is 37°C, the initial rotation speed is 200rpm, the initial ventilation rate is 1:0.5, and the pH value is controlled to 6.8 by adding concentrated ammonia water throughout the process. Dissolved oxygen was maintained at 30%-40% by increasing the rotating speed, ventilation and adding glucose-supplemented medium (60% glucose, 2% magnesium sulfate). When OD 600 When it reaches 20°C, adjust the temperature to 30°C, add IPTG (final concentration 0.5mM) to induce protein expression, and finish the fermentation after 10 hours, and harvest the cells by centrifugation at 8000rpm for 5min.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to polypeptide recombinant expression and purification, in particular to large-scale recombinant expression and purification of polypeptides containing many amino acids and richdisulfide bonds. The invention provides molecular chaperones-purification label-incision enzyme cutting site-toxic polypeptide Ssm6a fusion protein, which contains SEQ ID NO:1 and the variant amino acid sequence. The invention also provides a recombinant expression and purification method of toxin polypeptide Ssm6a from scolopendra mutilans venom.

Description

technical field [0001] The invention relates to the recombinant expression and purification of polypeptides, in particular to the large-scale recombinant expression and purification of polypeptides with a large number of amino acids and rich in disulfide bonds. Background technique [0002] Chronic pain affects more than 20% of the adult population and 50% of the elderly population, greatly reduces the quality of life of patients, and also poses a huge medical burden to countries. Current treatment for chronic pain mainly consists of the use of NSAIDs and opioids. Although non-steroidal anti-inflammatory drugs are widely used in the world, their analgesic range is small, and there are relatively common adverse reactions such as gastrointestinal tract, liver and kidney damage; while opioids have good analgesic effects, but There are serious adverse reactions such as addiction, hallucinations, and cardiopulmonary injury, as well as constipation and strong drug withdrawal symp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K1/22C07K1/18C12N15/62C12N15/70C12N1/21C12P21/06C12R1/19
Inventor 原桂勇殷海兴王凯健朱冠军谭莹莹
Owner 南通迈克爱伦医药有限公司